{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:57:53Z","timestamp":1794851873534,"version":"4.9.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007672","name":"National University of Singapore Mechanobiology Institute","doi-asserted-by":"publisher","award":["NRF-MSG-2023- 0001"],"award-info":[{"award-number":["NRF-MSG-2023- 0001"]}],"id":[{"id":"10.13039\/501100007672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["CIRG21nov-0032"],"award-info":[{"award-number":["CIRG21nov-0032"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["CIRG22jul-0018"],"award-info":[{"award-number":["CIRG22jul-0018"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.atherosclerosis.2026.120762","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:44:38Z","timestamp":1778579078000},"page":"120762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Organoid models reveal mechanistic connections and sirolimus efficacy in liver-vascular steatosis and foam cell formation"],"prefix":"10.1016","volume":"417","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0015-8708","authenticated-orcid":false,"given":"Vishnu Goutham","family":"Kota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan Low Jun","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apisara","family":"Yooyuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanry","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwa Liang","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.atherosclerosis.2026.120762_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015473","article-title":"Metabolic-dysfunction-associated steatotic liver disease-its pathophysiology, association with atherosclerosis and cardiovascular disease, and treatments","volume":"24","author":"Yanai","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120762_bib2","article-title":"Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease","volume":"328","author":"Kuchay","year":"2025"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120762_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.atherosclerosis.2026.120762_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.119053","article-title":"Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD","volume":"400","author":"Iturbe-Rey","year":"2025","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120762_bib5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2025.02.033","article-title":"Integrative metabolism in MASLD and MASH: pathophysiology and emerging mechanisms","volume":"83","author":"Steinberg","year":"2025","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120762_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26041778","article-title":"Current therapeutic landscape for metabolic dysfunction-associated steatohepatitis","volume":"26","author":"Devasia","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120762_bib7","article-title":"\"From LAL-D to MASLD: insights into the role of LAL and Kupffer cells in liver inflammation and lipid metabolism","volume":"1870","author":"Bradi\u0107","year":"2025","journal-title":"Biochim Biophys Acta, Mol Cell Biol Lipids"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120762_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202149641","article-title":"The \"domino effect\" in MASLD: the inflammatory cascade of steatohepatitis","volume":"54","author":"Mladeni\u0107","year":"2024","journal-title":"Eur J Immunol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120762_bib9","doi-asserted-by":"crossref","DOI":"10.2337\/dci24-0094","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD) in people with diabetes: the need for screening and early intervention. A consensus report of the American Diabetes Association","volume":"48","author":"Cusi","year":"2025","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120762_bib10","doi-asserted-by":"crossref","DOI":"10.7326\/ANNALS-24-02933","article-title":"Metabolic dysfunction-associated steatotic liver disease","volume":"178","author":"Ali","year":"2025","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120762_bib11","article-title":"Pathogenesis of MASLD and MASH - role of insulin resistance and lipotoxicity","volume":"59","author":"Bansal","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120762_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-024-02108-x","article-title":"Updated mechanisms of MASLD pathogenesis","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120762_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120762_bib14","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-016-2161-x","article-title":"Pathogenesis of nonalcoholic steatohepatitis","volume":"73","author":"Liu","year":"2016","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120762_bib15","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-024-01542-6","article-title":"Metabolic dysfunction-associated steatotic liver disease and atherosclerosis","volume":"24","author":"Castillo-N\u00fa\u00f1ez","year":"2024","journal-title":"Curr Diabetes Rep"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120762_bib16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/HEP.0000000000000735","article-title":"Metabolic dysfunction-associated steatotic liver disease and the heart","volume":"82","author":"Driessen","year":"2025","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120762_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.it.2019.10.002","article-title":"Foam cells: one size doesn't fit all","volume":"40","author":"Guerrini","year":"2019","journal-title":"Trends Immunol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120762_bib18","doi-asserted-by":"crossref","DOI":"10.1134\/S0006297912040025","article-title":"Macrophage\/foam cell is an attribute of inflammation: mechanisms of formation and functional role","volume":"77","author":"Dushkin","year":"2012","journal-title":"Biochemistry (Mosc)"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120762_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128163","article-title":"Foam cell formation in vivo converts macrophages to a pro-fibrotic phenotype","volume":"10","author":"Thomas","year":"2015","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.atherosclerosis.2026.120762_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Bor\u00e9n J","year":"2020","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120762_bib21","doi-asserted-by":"crossref","DOI":"10.1378\/chest.12-1044","article-title":"Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"142","author":"Baughman","year":"2012","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120762_bib22","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.01174.2006","article-title":"Anti-atherosclerotic effects of sirolimus on human vascular smooth muscle cells","volume":"292","author":"Ma","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.atherosclerosis.2026.120762_bib23","first-page":"9","article-title":"Rapamycin and FTY720 alleviate atherosclerosis by cross talk of macrophage polarization and autophagy","volume":"1010248","author":"Sun","year":"2018","journal-title":"BioMed Res Int"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120762_bib24","article-title":"Effects of sirolimus on mesangial cell cholesterol homeostasis: a novel mechanism for its action against lipid-mediated injury in renal allografts","volume":"289","author":"Varghese","year":"2005","journal-title":"Am J Physiol Heart Circulatory Physio Renal Physiol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120762_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26094054","article-title":"Empagliflozin alleviates hepatic steatosis and oxidative stress via the NRF1 pathway in high-fat diet-induced mouse model of metabolic dysfunction-associated steatotic liver disease","volume":"26","author":"Heo","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120762_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126332","article-title":"Empagliflozin improves metabolic and hepatic outcomes in a non-diabetic obese biopsy-proven mouse model of advanced NASH","volume":"22","author":"Perakakis","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.atherosclerosis.2026.120762_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107492","article-title":"The SGLT2 inhibitor empagliflozin negatively regulates IL-17\/IL-23 axis-mediated inflammatory responses in T2DM with NAFLD via the AMPK\/mTOR\/autophagy pathway","volume":"94","author":"Meng","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.atherosclerosis.2026.120762_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2022.07.048","article-title":"Empagliflozin inhibits macrophage inflammation through AMPK signaling pathway and plays an anti-atherosclerosis role","volume":"367","author":"Fu","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120762_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173040","article-title":"Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic Apolipoprotein E-Deficient mice","volume":"875","author":"Ganbaatar","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120762_bib30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12944-021-01430-y","article-title":"Empagliflozin protects against atherosclerosis progression by modulating lipid profiles and sympathetic activity","volume":"20","author":"Liu","year":"2021","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.atherosclerosis.2026.120762_bib31","article-title":"Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice","volume":"8","author":"Schweiger","year":"2017","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120762_bib32","doi-asserted-by":"crossref","DOI":"10.1124\/pr.118.017178","article-title":"Targeting foam cell formation in atherosclerosis: therapeutic potential of natural products","volume":"71","author":"Wang","year":"2019","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.atherosclerosis.2026.120762_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2018.08.002","article-title":"Foam cell formation: a new target for fighting atherosclerosis and cardiovascular disease","volume":"112","author":"Maguire","year":"2019","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2026.120762_bib34","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.biopha.2017.11.041","article-title":"CML\/CD36 accelerates atherosclerotic progression via inhibiting foam cell migration","volume":"97","author":"Xu","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120762_bib35","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1186\/s12967-025-07402-5","article-title":"Foam cells: tracing the diverse cellular origins and their linked signaling pathways","volume":"23","author":"Jiao","year":"2025","journal-title":"J Transl Med"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120762_bib36","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00109-010-0629-y","article-title":"Inhibition of foam cell formation using a soluble CD68-Fc fusion protein","volume":"88","author":"Daub","year":"2010","journal-title":"J Mol Med"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120762_bib37","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/CIRCRESAHA.111.240515","article-title":"Effect of the oxLDL binding protein Fc-CD68 on plaque extension and vulnerability in atherosclerosis","volume":"108","author":"Zeibig","year":"2011","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120762_bib38","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/ATVBAHA.119.312557","article-title":"Revealing the origins of foam cells in atherosclerotic lesions","volume":"39","author":"Owsiany","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2026.120762_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35485-2","article-title":"IL-34 promotes foam cell formation by enhancing CD36 expression through p38 MAPK pathway","volume":"8","author":"Liu","year":"2018","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120762_bib40","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1074\/jbc.M113.524512","article-title":"Endoplasmic reticulum stress promotes macrophage-derived foam cell formation by up-regulating cluster of differentiation 36 (CD36) expression","volume":"289","author":"Yao","year":"2014","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120762_bib41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/dna.2013.2164","article-title":"mTOR enhances foam cell formation by suppressing the autophagy pathway","volume":"33","author":"Wang","year":"2014","journal-title":"DNA Cell Biol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120762_bib42","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.3892\/mmr.2017.7032","article-title":"mTOR signaling promotes foam cell formation and inhibits foam cell egress through suppressing the SIRT1 signaling pathway","volume":"16","author":"Zheng","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.atherosclerosis.2026.120762_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.845942","article-title":"Foam cells in atherosclerosis: novel insights into its origins, consequences, and molecular mechanisms","volume":"9","author":"Gui","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2026.120762_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.574047","article-title":"Liver organoids: recent developments, limitations and potential","volume":"8","author":"Harrison","year":"2021","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120762_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13287-025-04139-2","article-title":"Advances in liver organoids: replicating hepatic complexity for toxicity assessment and disease modeling","volume":"16","author":"Shao","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.atherosclerosis.2026.120762_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.790529","article-title":"Recent progress in in vitro models for atherosclerosis studies","volume":"8","author":"Chen","year":"2022","journal-title":"Front Cardiovasc Med"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026001280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026001280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:46:40Z","timestamp":1783136800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026001280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":46,"alternative-id":["S0021915026001280"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120762","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organoid models reveal mechanistic connections and sirolimus efficacy in liver-vascular steatosis and foam cell formation","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120762"}}